Clinical Trials Logo

Clinical Trial Summary

The incidence of myocardial injury after non-cardiac surgery (MINS) is approximately 12-15% and is associated with an increased risk of 30-day mortality, 1-year mortality, and 2-year major vascular events. Using both traditional longitudinal analysis techniques and novel methods in machine learning, investigators will explore whether intraoperative and postoperative vital signs can enhance MINS surveillance by providing temporal prediction of MINS events.


Clinical Trial Description

The incidence of myocardial injury after non-cardiac surgery (MINS) is approximately 12-15% and is associated with an increased risk of 30-day mortality, 1-year mortality, and 2-year major vascular events. Since more than 90% of patients with MINS are asymptomatic, routine troponin monitoring is required for detection. The postoperative days 0, 1, and 2 accounts for approximately 40%, 40%, and 10% of MINS, respectively. Presently, the Canadian Cardiovascular Society (CCS) perioperative guidelines recommend patients identified to be at risk according to the Revised Cardiac Risk Index (RCRI) and BNP/NT-pro B-type Natriuretic Peptide (NT-pro BNP) receive daily postoperative troponin monitoring for three days to identify MINS events (5). European and American societies have similar recommendations for troponin monitoring to detect MINS. Current risk stratification models have multiple limitations. Most importantly, they predict an elevated risk over the postoperative period but cannot pinpoint when MINS may happen in the postoperative course given the patients' changing condition. Moreover, prescription of troponin monitoring is not universal, infrequent and inconsistent troponin monitoring may lead to delayed detection and management, and the rise of troponin is delayed by 3-4 hours from the time of injury. Retrospective cohort studies show association amongst intraoperative and postoperative derangements in vital signs and MINS. Vital signs are routinely available within the electronic medical record, and may serve as objective predictors (i.e. as opposed to free text and disease names that have higher risks of misclassification and errors). Using both traditional longitudinal analysis techniques and novel methods in machine learning, investigators will explore whether intraoperative and postoperative vital signs can enhance MINS surveillance by providing temporal prediction of MINS events. Objectives 1. To develop and internally validate a model that uses the duration and degree of intraoperative and postoperative hypotension to predict the daily maximum troponin level from postoperative days zero to two, in a high risk population where troponin monitoring was ordered. 2. To develop and internally validate a model that uses the duration and degree of intraoperative and postoperative hypotension to predict daily probability of MINS or death (binary outcome, according to the 2021 American Heart Association (AHA) definitions from postoperative days zero to two. 3. To evaluate how different definitions of hypotension affect the primary and secondary models above, and analyze the intraoperative and postoperative hypotension separately to determine whether intraoperative or postoperative hypotension alone are sufficient for prediction. 4. To explore whether other intraoperative and postoperative vital sign information (heart rate, oxygen saturation, and end-tidal carbon dioxide derangements at various definitions) add predictive value to the primary and secondary models above. 5. To use machine learning methods to perform exploratory analysis to determine 1) optimal methods for imputation for time series data; 2) visualization of time series data in the setting of prediction; 3) development and internal validation of machine learning models to use the time series data to predict troponin levels; and 4) to determine how many hours earlier than a binary MINS diagnosis were vital signs able to predict a MINS diagnosis (as determined by when in the time series prior to MINS diagnosis that the model achieved various thresholds of predicted probability). Preoperative laboratory values are collected within 30 days before surgery. Preoperative vitals are collected within 24 hours before surgery. The total duration of subsequent data collection will be from the time of surgery up to postoperative day 3 (since the MINS protocol monitors for 3 days) or hospital discharge or death, whichever occurs first. Since 90% of MINS happen between postoperative days zero and two and the frequency of monitoring would likely decrease by postoperative day 3, investigators will model troponin from postoperative day 0 to postoperative day 2 for the primary analysis to balance utility of the temporal model and prediction data quality. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05188001
Study type Observational
Source University of British Columbia
Contact
Status Active, not recruiting
Phase
Start date January 1, 2022
Completion date December 31, 2022

See also
  Status Clinical Trial Phase
Terminated NCT03940651 - Cardiac and Renal Biomarkers in Arthroplasty Surgery Phase 4
Completed NCT01688648 - Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft N/A
Recruiting NCT04794062 - Myocardial Injury and Quality of Life After COVID-19
Recruiting NCT04750616 - NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial Phase 2
Withdrawn NCT04139655 - Colchicine Prevents Myocardial Injury After Non-Cardiac Surgery Pilot Study N/A
Recruiting NCT04436016 - PeRiOperaTivE CardioproTection With Ivabradine in Non-cardiac Surgery Phase 4
Active, not recruiting NCT03338504 - Determining the Mechanism of Myocardial Injury and Role of Coronary Disease in Type 2 Myocardial Infarction
Recruiting NCT03013634 - Protective Effects of Dexmedetomidine on Myocardial Injury During Liver Transplantation N/A
Completed NCT00007358 - Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus N/A
Recruiting NCT04624503 - Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19
Recruiting NCT03339180 - Cardiac Injury in Patients With Influenza
Completed NCT03010839 - Cardiopulmonary Protective Effects of Modified Remote Ischaemic Preconditioning in Mitral Valve Replacement Surgery N/A
Not yet recruiting NCT04615871 - Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19 Phase 2
Recruiting NCT04743765 - HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial N/A
Enrolling by invitation NCT03253835 - Cardiac Blood Flow Patterns Associated With Left Ventricular Myocardial Damage
Completed NCT00817791 - Preconditioning With Hyperbaric Oxygen in Cardiovascular Surgery N/A
Recruiting NCT04149314 - The "Hypotension Prediction Index" in Patients Undergoing Lung Surgery N/A
Suspended NCT03191461 - Myocardial Perfusion and Fibrosis in Cancer Survivors
Completed NCT01903161 - Effect of Delayed Remote Ischemic Preconditioning on Myocardial Injury N/A
Recruiting NCT01608984 - Effects of Remote Ischemic PreConditioning in Off-pump Versus On-pump Coronary Artery Bypass Grafting(RIPCON) Phase 1